Table 2.
Lung cancer screening completion by guideline, risk status and race
| Patient Race | Eligible (USPSTF2013) | Provider recommendations (of eligible) | Screens received (of referred) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Complete Cases | Estimate | 95% CI | Complete Cases | Estimate | 95% CI | Complete Cases | Estimate | 95% CI | |
| White | 127 / 531 | 27.9% | 24.7%,30.9% | 63 / 121 | 45.1% | 35.2%,56.1% | 55 / 58 | 96.9% | 79.0%,100.0% |
| Black | 90 / 483 | 14.0% | 10.3%,18.1% | 53 / 85 | 35.3% | 23.2%,49.5% | 26 / 31 | 78.1% | 38.0%,100.0% |
| All^ | 217 / 797 | 23.6%* | 20.6%,26.2% | 90 / 206 | 37.1% | 30.3%,46.8% | 81 / 89 | 88.1%+ | 82.5%,92.6% |
US Preventive Services Task Force (USPSTF), 2013 indicated the 2013 guidelines for lung cancer screening ^All reported races; *Significant difference in eligibility for screening between Black and White patients p < .05; +Significant difference in completion of screening between Black and White patients among those referred for screening p < .05; Complete Cases columns represents the raw frequencies for complete cases ignoring missing data. Frequencies will be slightly different when compared to Table 1 because of this